Country: Australia
Language: English
Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)
OESTRIOL
INTERVET AUSTRALIA PTY LIMITED
oestriol(1mg/Tb)
ORAL TABLET
OESTRIOL HORMONE Active 1.0 mg/Tb
30 Tablets
VM - Veterinary Medicine
INTERVET AUSTRALIA
DOG - BITCH - OVARIOHYSTERECTOMISED
ENDOCRINE SYSTEM
INCONTINENCE - HORMONE RESPONSIVE
Poison schedule: 4; Withholding period: WHP:N/A; Host/pest details: DOG - BITCH - OVARIOHYSTERECTOMISED: [INCONTINENCE - HORMONE RESPONSIVE]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG - BITCH - OVARIOHYSTERECTOMISED: [INCONTINENCE - HORMONE RESPONSIVE]; An aid in the treatment of hormone-responsive urinary incontinence due to sphincter mechanism in ovariohysterectomised bitches.Do not use in intact bitches. See leaflet also.
Registered
2023-07-01
An aid in the treatment of hormone-responsive urinary incontinence due to sphincter mechanism incompetence in ovariohysterectomised bitches. 30 Tablets INTERVET AUSTRALIA PTY LIMITED 91-105 Harpin Street, BENDIGO EAST VIC 3550 Phone: (03) 5440 9888 READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. DIRECTIONS FOR USE: CONTRAINDICATIONS: Do not use in intact bitches as the efficacy has only been established in ovariohysterectomised bitches. Animals showing a polyuria-polydipsia should not be treated with INCURIN ® . Excretion is primarily via the bile. Use with caution in animals with liver disease. SIDE EFFECTS: High doses of oestrogen may have a tumour promoting effect in target organs with oestrogen receptors (mammary gland). Oestrogenic effects such as swollen vulva, swollen mammary glands and/or attractiveness to males and vomiting have been observed at the highest recommended dose of 2 mg per dog. The incidence is about 5-9%. These effects are reversible after lowering the dose. In rare cases vaginal bleeding occurred. Alopecia is a potential side effect, particularly with long term use. DOSAGE AND ADMINISTRATION: For oral administration. FIRST AID: If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131126. DISPOSAL: Dispose of empty container by wrapping with paper and putting in garbage. STORAGE: Store below 30°C (Room temperature). APVMA Approval No.: 57787/30T/0904 0497573A 5150.880.2961 Batch No. : Expiry Date : INCURIN ® ACTIVE CONSTITUENT: OESTRIOL, 1 mg/TABLET 049573A 5150 / 328 INCURIN ® ACTIVE CONSTITUENT: OESTRIOL, 1 mg/TABLET INCURIN ® ACTIVE CONSTITUENT: OESTRIOL, 1 mg/TABLET PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY 042/5150/880/049573A 09-11-2004 14:38 Pagina 1 Info PEST Verified GENERAL DIRECTIONS: Oestriol is a short-acting natural oestrogen. After oral administration of multiple doses no accumulation occurs. In the target animal safety study and the clinical trials, including long-term treatment, no signs of Read the complete document
PRODUCT NAME: INCURIN® MATERIAL SAFETY DATA SHEET THIS REVISION ISSUED: JULY, 2009 PAGE: 1 OF 5 MATERIAL SAFETY DATA SHEET Issued by: Intervet Australia Pty Limited Phone: 1 800 033 461 (Business Hours) Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800 764 766 in New Zealand) SUBSTANCE: Oestriol is an estrogen compound. TRADE NAME: INCURIN ® PRODUCT CODE: 68038 RECOMMENDED USE: Incontinence treatment for female dogs. APVMA NO: 57787 CREATION DATE: November, 2006 THIS VERSION ISSUED: July, 2009 and is valid for 5 years from this date. STATEMENT OF HAZARDOUS NATURE: THIS PRODUCT IS CLASSIFIED AS: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S20, S45. When using, do not eat or drink. In case of accident or if you feel unwell, contact a doctor or Poisons Information Centre immediately (show the label where possible). SUSDP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated PHYSICAL DESCRIPTION & COLOUR: White tablets. ODOUR: No odour. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. INHALATION: SHORT TERM EXPOSURE: Long term inhalation of high amounts of any nuisance dust may overload lung clearance mechanism. Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. LONG TERM EXPOSURE: No data for health effects associated with long term inhalation. SKIN CONTACT: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. It should present no hazards in normal use. In addition product is unlikely to cause any discomfort in normal use. LONG TERM EXPOSURE: No data for health effects associated with long term skin exposure. EYE CONTACT: SHORT TERM EXPOSURE : This product may be mildly irritating to eyes, but is unlikely to cause anything more tha Read the complete document